Miltefosine in the treatment of a case of visceral leishmaniasis with renal dysfunction

By Kumar N.   Pandey K.   Das V. N. R.   Sinha P. K.   Topno R. K.   Verma N.   Lal C. S.   Das P.   Bhattacharya S. K.  

Annals of Tropical Medicine and Parasitology, Vol. 101, Iss. 7, 2007-10 ,pp. : 649-651

Maney Publishing

Access to resources Recommend Favorite

Miltefosine for visceral leishmaniasis relapse treatment and secondary prophylaxis in HIV-infected patients

By Marques Nuno   Sa Rosa   Coelho Filomena   Oliveira Joaquim   Saraiva Da Cunha J.   Melico-Silvestre A.  

Scandinavian Journal of Infectious Diseases, Vol. 40, Iss. 6-7, 2008-01 ,pp. : 523-526

Informa Healthcare

Access to resources Recommend Favorite

Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine

By Kumar D.   Ramesh V.   Verma S.   Ramam M.   Salotra P.  

Annals of Tropical Medicine and Parasitology, Vol. 103, Iss. 8, 2009-12 ,pp. : 727-730

Maney Publishing

Access to resources Recommend Favorite

Successful use of miltefosine and sodium stibogluconate, in combination, for the treatment of an HIV-positive patient with visceral leishmaniasis: a case report and brief review of the literature

By Collini P.   Premchand N.   Lockwood D.   Greig J.  

Annals of Tropical Medicine and Parasitology, Vol. 103, Iss. 5, 2009-07 ,pp. : 455-459

Maney Publishing

Access to resources Recommend Favorite

Successful miltefosine treatment of post-kala-azar dermal leishmaniasis occurring during antiretroviral therapy

By Belay A. Dejenie   Asafa Y.   Mesure J.   Davidson R. N.  

Annals of Tropical Medicine and Parasitology, Vol. 100, Iss. 3, 2006-04 ,pp. : 223-227

Maney Publishing

Access to resources Recommend Favorite